ClinicalTrials.gg
Biological

Lonoctocog alfa clinical trials

Also written CSL627 and rVIII-SingleChain.

studies test it
4
open now
0
in phase 3
4
first study started
2012

How each study uses lonoctocog alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
25 May 2016 · Afstyla · BLA 125591 (FDA, Purple Book)
European Union
4 Jan 2017 · Afstyla · EMEA/H/C/004075 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

CSL627
4

Other names

rVIII-SingleChain
3

Studies by the year they started

4 studies that test it; most in 2014 (2)

Studies that test lonoctocog alfa, by start year
YearStudies
20121
20142
20251

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 0

CSL Behring (4)

Often tested with

Tested in the same studies.

F8 protein, human (1)

Studies

Open first, then newest update. How each study uses lonoctocog alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

Codes

What other systems call lonoctocog alfa · ClinicalTrials.gg INT018264

  • UNII (FDA) VQ723R7O8RLONOCTOCOG ALFAOne source FDA
  • RxNorm 1796377One source FDA
  • NCI Thesaurus C170127Lonoctocog AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.